In an interview with CURE, Dr. Susana Campos, clinical director of the Division of Gynecologic Oncology and assistant professor of medicine at Harvard Medical School, discussed re ...
Analysis of data from over 1.2 million US patients with gynecologic cancers between 2004 and 2020 revealed a significant shift towards surgical de-escalation, with increased use of minimally invasive ...
“These are frequently lethal cancers if they’re found later on,” said Dr. J. Brian Szender, chief of Surgery at Methodist Stone Oak, he also the Gynecologic Oncology Program Director at the START ...
Several drug classes, including immunotherapy, antibody-drug conjugates and PARP inhibitors have helped improve outcomes for gynecologic cancers. Over the past 10 years, PARP inhibitors, immunotherapy ...
Symptoms of cervical, uterine, ovarian, and vaginal cancers can include abnormal vaginal bleeding or discharge; of ovarian cancer may include bloating, feeling full quickly, and abdominal or back pain ...
Women with gynecologic cancers who meet criteria for malnutrition before surgery face a higher risk for poor postoperative outcomes. However, the value of preoperative malnutrition assessments depends ...
ChatGPT can accurately answer common questions pertaining to genetic testing and counseling for gynecologic cancers but stumbles when asked to provide the appropriate treatment option, according to a ...
The comprehensive study shows 4.7% of women experienced early death, but rates varied dramatically for Black women across gynecologic cancers. A comprehensive study led by Dr. Matthew W. Lee of the ...
Study data from patients with relapsed or refractory gynecologic cancers signals the potential of LYMPHIR to augment immune checkpoint inhibitor efficacy Topline data ...
(Editor's note Aug. 27, 2024: Kemi Doll, MD, MCSR, is a professor in the University of Washington Department of Obstetrics and Gynecology. She does not see patients at Fred Hutch.) Fred Hutchinson ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Several novel treatment regimens for gynecologic cancer ...
The discrepancy isn't just in the rate of occurrence — it’s also caused by tumor location.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results